RGNX - JPM

u/fbksminer · Reddit — r/biotech_stocks · January 14, 2026 at 21:29 · ⬆ 4 pts  | View on Reddit ↗
AI Summary

Original Reddit post

Author is bullish Regenxbio after a strong JPM Healthcare conference call, citing H1 2026 milestones including a first PDUFA, first dose in DR phllb/lll, and pivotal DMD data.

RGNX — LONG The author reports a great JPM Healthcare conference call for Regenxbio and points to several H1 2026 milestones: a first PDUFA, first dose in DR phllb/lll, and pivotal data for DMD. They expect it to be a great year and recommend due diligence. No specific risk is stated.

Looking forward to H1 26 with several milestones coming. 1st pdufa, 1st dose in DR phllb/lll, and pivotal data for DMD.

Score 4
Full Post Text
Ideas
u/fbksminer Reddit r/biotech_stocks
Regenxbio H1 2026 milestone catalysts
The author reports a great JPM Healthcare conference call for Regenxbio and points to several H1 2026 milestones: a first PDUFA, first dose in DR phllb/lll, and pivotal data for DMD. They expect it to be a great year and recommend due diligence. No specific risk is stated.
More from Reddit — r/biotech_stocks

This Reddit post, published January 14, 2026, features u/fbksminer discussing RGNX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/fbksminer  · Tickers: RGNX